.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent clinical evidence explores the utilization of adjuvant radiation for PDAC. According to a large-scale database study evaluating the RTOG 0848 protocol, utilization of this modality has significantly declined over the last two decades. While adjuvant radiation rates dropped from 45% to 12%, neoadjuvant radiation rates simultaneously tripled. However, researchers identified that patients with specific pathologic features still derive substantial benefits from this treatment.
The study utilized the National Cancer Database to analyze survival outcomes in a cohort mimicking the RTOG 0848 trial criteria. Notably, clinicians observed improved overall survival in patients with node-negative disease and positive surgical margins who received adjuvant radiation for PDAC. Specifically, median survival increased from 23.0 to 28.6 months in this high-risk group. Consequently, positive margins and nodal involvement remain the primary predictors for radiation receipt. Therefore, these findings suggest that while broad application is decreasing, targeted use remains vital for specific subgroups. Furthermore, this real-world data reinforces the importance of careful patient selection in modern oncological practice.
While overall usage is declining in favor of neoadjuvant approaches, it remains highly beneficial for specific subgroups, particularly those with node-negative disease and positive surgical margins.
The strongest predictors for receiving adjuvant radiation include positive surgical margins and nodal disease, as these factors typically indicate a higher risk of local recurrence.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Professional medical consultations are necessary for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
1. Dickey EM et al. Trend of Adjuvant Radiation in Resected Pancreatic Ductal Adenocarcinoma: Evaluation of RTOG 0848 with a Large National Database. J Gastrointest Cancer. 2026 May 25. doi: undefined. PMID: 42184090.
2. Abrams RA, et al. Results of the NRG Oncology/RTOG 0848 adjuvant chemotherapy question: erlotinib + gemcitabine for resected cancer of the pancreatic head. J Clin Oncol. 2020;38(27):3139-3147.
3. National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma. Version 2.2024.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A database study reveals declining rates of adjuvant radiation for pancreatic cancer, though survival benefits persist in specific node-negative patient gro...
2 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
